Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Berit X. Carlson"'
Autor:
Berit X. Carlson, James M. Eudicone, Michael E. Thase, Robert D. McQuade, Ronald N. Marcus, Charles L. Bowden, Michael Nashat
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 16:121-131
This post-hoc analysis of pooled data from two similarly designed trials assessed the impact of aripiprazole monotherapy vs. placebo on treatment outcomes based on baseline severity of core depressive symptoms in patients with bipolar I disorder.Pati
Autor:
Karen Timko, Robert D. McQuade, Estelle Vester-Blokland, Ronald N. Marcus, Terence A. Ketter, Berit X. Carlson, Raymond Sanchez, Wei Sun
Publikováno v:
Bipolar Disorders. 14:41-53
Carlson BX, Ketter TA, Sun W, Timko K, McQuade RD, Sanchez R, Vester-Blokland E, Marcus R. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, doubl
Autor:
Anzalee Khan, James M. Eudicone, Quynh Van Tran, Robert M. Berman, Berit X. Carlson, Hsuanchih Yang, Richard H. Weisler, Madhukar H. Trivedi, Andrei Pikalov
Publikováno v:
The Journal of Clinical Psychiatry. 72:548-555
To assess the impact of adjunctive aripiprazole versus adjunctive placebo treatment on suicidality in patients with major depressive disorder.Data were pooled from 2 identical aripiprazole augmentation studies. Patients with DSM-IV-TR-diagnosed major
Autor:
Quynh-Van Tran, J. Craig Nelson, Robert M. Berman, Andrei Pikalov, Ross A. Baker, Raymond Mankoski, James M. Eudicone, Berit X. Carlson
Publikováno v:
Journal of Affective Disorders. 120:133-140
Although antipsychotic agents have a long history of use in depression, their effectiveness in treating core symptoms of depression such as loss of interest has been questioned. Adjunctive aripiprazole is beneficial for the treatment of patients with
Autor:
Stephen R. Wisniewski, Zhenchao Guo, Andrei Pikalov, Quynh Van Tran, Chi Chang Chen, Hong J. Kan, Edward Kim, Berit X. Carlson
Publikováno v:
Pharmacoepidemiology and Drug Safety. 18:965-972
Objective This study quantified the overall merit of adjunctive aripiprazole in major depressive disorder (MDD). Methods Global benefit–risk (GBR) analysis quantified the benefit and risk differences between adjunctive aripiprazole and antidepressa
Autor:
Berit X. Carlson, Huyuan Yang, J. Craig Nelson, Ying Qi, Maurizio Fava, Madhukar H. Trivedi, Michael E. Thase, Robert M. Berman, Andrei Pikalov, Ronald N. Marcus, Quynh Van Tran
Publikováno v:
The Journal of Clinical Psychiatry. 69:1928-1936
OBJECTIVE To evaluate the efficacy of adjunctive aripiprazole to standard antidepressant therapy (ADT) for patients with DSM-IV major depressive disorder with anxious/atypical features at baseline. METHOD Data from 2 identical 14-week studies (an 8-w
Autor:
Robert D. McQuade, C. Momah, Berit X. Carlson, A. Pikalov, R. Marcus, Raymond Sanchez, D. J. Muzina, James M. Eudicone
Publikováno v:
International Journal of Clinical Practice. 62:679-687
Summary Aims: Rapid-cycling bipolar disorder is difficult to treat and associated with greater morbidity than non-rapid-cycling disease. This post hoc analysis evaluated 28 patients with rapid-cycling bipolar I disorder from a 100-week, double-blind,
Autor:
Robert D. McQuade, James M. Eudicone, Ronald N. Marcus, Roger S. McIntyre, Raymond Sanchez, Paul E. Keck, William H. Carson, Berit X. Carlson, Calabrese
Publikováno v:
The Journal of Clinical Psychiatry. 68:1480-1491
A 26-week, double-blind, placebo-controlled relapse prevention study of aripiprazole was designed a priori with a prospective, 74-week, double-blind, placebo-controlled extension phase. Efficacy and tolerability of aripiprazole for relapse prevention
Autor:
Alan C. Swann, James M. Eudicone, Trisha Suppes, Berit X. Carlson, Wally Landsberg, Michael J. Ostacher, Ross A. Baker
Publikováno v:
International Journal of Bipolar Disorders
Background A previous factor analysis of Young Mania Rating Scale and Montgomery-Åsberg Depression Rating Scale items identified composite factors of depression, mania, sleep disturbance, judgment/impulsivity, and irritability/hostility as major com
Publikováno v:
European Journal of Pharmacology. 352:1-14
The cerebellum undergoes many morphological, pharmacological, and electrophysiological changes during the first 3 weeks of postnatal development. The purpose of this review is to present the most up to date synopsis of the pharmacological and functio